Abstract
Diabetes is a highly complex disease. Despite many different pharmacological alternatives to treat diabetes, they simply slow the illness's progression. Once installed, it becomes a pathology that cannot be cured. Its significant growth worldwide makes it challenging for governments to manage the high costs of treating people suffering from diabetes. Many research investigations are carried out, and prominent pharmaceutical corporations emphasize the creation of novel medicines. The present lifestyles, diets, and sedentary behavior of the population have exacerbated the disease. Diabetes must find new approaches for new studies and methodologies focusing on the pathometabolic signaling and early manifestations of hyperglycemia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Endocrinology&Metabolism International Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
